Therefore, the aim of this study was to elucidate the clinical relevance of these TYMS polymorphisms, by genotype and haplotype-based approaches, in MTX therapeutic outcome of Portuguese RA patients. This evidence concerns the gene TYMS and rheumatoid arthritis.